Effect of Local Anti-VEGF Antibody Treatment on Tumor Microvessel Permeability

Author： Lichtenbeld H.C. Ferarra N. Jain R.K. Munn L.L.

ISSN： 0026-2862

Source： Microvascular Research, Vol.57, Iss.3, 1999-05, pp. : 357-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preovulatory Treatment of Mice with Anti-VEGF Receptor 2 Antibody Inhibits Angiogenesis in Corpora Lutea

By Zimmermann R.C. Hartman T. Bohlen P. Sauer M.V. Kitajewski J.

Microvascular Research, Vol. 62, Iss. 1, 2001-07 ,pp. : 15-25

Academic Press

Access to resources Recommend Favorite

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

By Wang Yaning

Angiogenesis, Vol. 7, Iss. 4, 2004-12 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Anti-VEGF Anticancer Drugs: Mind the Hypertension

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 63-72

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease

Digestion, Vol. 88, Iss. 1, 2013-06 ,pp. : 17-19

Karger

Access to resources Recommend Favorite